Matthew B. Frankel - Nov 14, 2022 Form 3 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Chief Medical Officer
Signature
/s/ Matthew B. Frankel
Stock symbol
CMMB
Transactions as of
Nov 14, 2022
Transactions value $
$0
Form type
3
Date filed
11/15/2022, 03:03 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMMB Options to Purchase American Depositary Shares Nov 14, 2022 American Depositary Shares 125K $2.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2 25% of these options will vest and become exercisable on the first anniversary of November 14, 2022, and the remaining 75% of these options will vest in equal amounts over a 36-month period commencing on November 14, 2023, subject to the Reporting Person's continued service.